These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8321048)

  • 1. c-fms point mutations in acute myeloid leukemia: fact or fiction?
    Springall F; O'Mara S; Shounan Y; Todd A; Ford D; Iland H
    Leukemia; 1993 Jul; 7(7):978-85. PubMed ID: 8321048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia.
    Christiansen DH; Andersen MK; Desta F; Pedersen-Bjergaard J
    Leukemia; 2005 Dec; 19(12):2232-40. PubMed ID: 16281072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele-specific enrichment: a method for the detection of low level N-ras gene mutations in acute myeloid leukemia.
    Todd AV; Ireland CM; Iland HJ
    Leukemia; 1991 Feb; 5(2):160-1. PubMed ID: 2020198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.
    Tobal K; Pagliuca A; Bhatt B; Bailey N; Layton DM; Mufti GJ
    Leukemia; 1990 Jul; 4(7):486-9. PubMed ID: 2142747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia.
    Taylor C; McGlynn H; Carter G; Baker AH; Warren N; Ridge SA; Owen G; Thompson E; Thompson PW; Jacobs A
    Leukemia; 1995 Mar; 9(3):466-70. PubMed ID: 7885045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of N-ras gene mutations in acute myeloid leukemia by allele specific restriction analysis.
    Todd AV; Ireland CM; Radloff TJ; Kronenberg H; Iland HJ
    Am J Hematol; 1991 Nov; 38(3):207-13. PubMed ID: 1951319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of point mutations in a functionally important part of the extracellular domain of the c-kit proto-oncogene in a series of patients with acute myeloid leukemia (AML).
    Arland M; Fiedler W; Samalecos A; Hossfeld DK
    Leukemia; 1994 Mar; 8(3):498-501. PubMed ID: 8127154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective analysis of ras gene activation in myeloid leukemic cells.
    Lübbert M; Jonas D; Miller CW; Herrmann F; Mertelsmann R; McCormick F; Koeffler HP
    Oncogene; 1990 Apr; 5(4):583-7. PubMed ID: 2183160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
    Niimi H; Harada H; Harada Y; Ding Y; Imagawa J; Inaba T; Kyo T; Kimura A
    Leukemia; 2006 Apr; 20(4):635-44. PubMed ID: 16467864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes.
    Neubauer A; Greenberg P; Negrin R; Ginzton N; Liu E
    Leukemia; 1994 Apr; 8(4):638-41. PubMed ID: 7512175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FMS mutations in myelodysplastic, leukemic, and normal subjects.
    Ridge SA; Worwood M; Oscier D; Jacobs A; Padua RA
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1377-80. PubMed ID: 2406720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.
    Needleman SW; Devine SE; Kraus MH
    Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [N-ras and fms gene mutation in idiopathic thrombocytopenic purpura and myelodysplasia].
    Zhao HY; Hou M; Li XF; Ma DX; Liu QJ; Wang P
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):158-60. PubMed ID: 18788612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia.
    Shih LY; Huang CF; Wang PN; Wu JH; Lin TL; Dunn P; Kuo MC
    Leukemia; 2004 Mar; 18(3):466-75. PubMed ID: 14737077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple point mutation of N-ras and K-ras oncogenes in myelodysplastic syndrome and acute myelogenous leukemia.
    Nakagawa T; Saitoh S; Imoto S; Itoh M; Tsutsumi M; Hikiji K; Nakamura H; Matozaki S; Ogawa R; Nakao Y
    Oncology; 1992; 49(2):114-22. PubMed ID: 1574246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic disorders with hemizygous M-CSF receptor gene loss do not show point mutations of codon 969 within the remaining allele.
    Jaquet K; Kreipe H; Felgner J; Boultwood J; Parwaresch MR
    Leukemia; 1993 Apr; 7(4):650-2. PubMed ID: 8464244
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.
    Auewarakul CU; Lauhakirti D; Tocharoentanaphol C
    Eur J Haematol; 2006 Jul; 77(1):51-6. PubMed ID: 16573741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias.
    Ludwig L; Janssen JW; Schulz AS; Bartram CR
    Leukemia; 1993 Jul; 7(7):1058-60. PubMed ID: 8321021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia.
    Scholl S; Krause C; Loncarevic IF; Müller R; Kunert C; Wedding U; Sayer HG; Clement JH; Höffken K
    J Lab Clin Med; 2005 Jun; 145(6):295-304. PubMed ID: 15976757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.